Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 20/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5541925 | 0.81 | NOTUM (1.00) | NOTUM | |
| SCHEMBL5544153 | 0.81 | NOTUM (1.00) | NOTUM | |
| SCHEMBL5542943 | 0.81 | NOTUM (0.92) | NOTUM | |
| SCHEMBL5547617 | 0.81 | NOTUM (0.68) | NOTUM | |
| SCHEMBL2898202 | 0.81 | NOTUM (1.00) | NOTUM | |
| SCHEMBL7323238 | 0.81 | NOTUM (0.68) | NOTUM | |
| SCHEMBL5542637 | 0.80 | NOTUM (1.00) | NOTUM | |
| SCHEMBL2291570 | 0.79 | NOTUM (0.67) | NOTUM | |
| Neovadrine SCHEMBL5537403 | 0.78 | NOTUM (0.69) | NOTUM | |
| SCHEMBL1500521 | 0.77 | NOTUM (0.67) | NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210115058-A1 | SPIROCYCLIC COMPOUNDS | RECURIUM IP HOLDINGS, LLC | 2021-04-22 | — | — | US | disclosed |
| US-10934304-B2 | Spirocyclic compounds | RECURIUM IP HOLDINGS, LLC (US) | 2021-03-02 | — | — | US | disclosed |
| US-20200207776-A1 | SPIROCYCLIC COMPOUNDS | Zeno Royalties & Milestones, LLC | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115058-A1 | SPIROCYCLIC COMPOUNDS | PKD1, AR, PKD2 | NOTUM 3667/4885 |
| US-20200207776-A1 | SPIROCYCLIC COMPOUNDS | PKD1, AR, PKD2 | NOTUM 3667/4885 |
| US-10934304-B2 | Spirocyclic compounds | PKD1, AR, PKD2 | NOTUM 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.